Immupharma (IMM) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. Immupharma

NOTE: This is based on 7 open tips for Immupharma (IMM)


Immupharma (IMM)
Latest Quote Price

1.20p

Immupharma (IMM)
Price Change (%)

-13.28%


Latest Bid : 1.10p Latest Ask : 1.22p
High Today : 1.29p Low Today : 1.08p
This Years High : 2.61p This Years Low : 0.85p
Volume : 1,442,197 MKT Cap : £4.99M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Immupharma (IMM) Overview

ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company's most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.

Immupharma (IMM) Latest Tips

Type Tipster SectorScore Start date Performance
Buy Northland Capital Premium Only 2018-04-17 16:35:00 17/04/2018 -60.41%
Risky Buy Paul Summers Premium Only 2018-03-01 09:50:00 01/03/2018 -92.31%
Buy FinnCap Premium Only 2017-12-21 11:30:00 21/12/2017 -91.87%
Buy FinnCap Premium Only 2017-12-12 08:00:00 12/12/2017 -93.10%
Buy Harvey Jones Premium Only 2017-10-09 15:30:00 09/10/2017 -86.07%

Premium Content

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Immupharma (IMM) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 1.10p Latest Ask : 1.22p
High Today : 1.29p Low Today : 1.08p
This Years High : 2.61p This Years Low : 0.85p
Volume : 1,442,197 MKT Cap : £4.99M

Immupharma Overview

ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company's most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Immupharma Tips

Type Tipster SectorScore Start date Performance
Buy Northland Capital Premium Only 2018-04-17 16:35:00 17/04/2018 -60.41%
Risky Buy Paul Summers Premium Only 2018-03-01 09:50:00 01/03/2018 -92.31%
Buy FinnCap Premium Only 2017-12-21 11:30:00 21/12/2017 -91.87%
Buy FinnCap Premium Only 2017-12-12 08:00:00 12/12/2017 -93.10%
Buy Harvey Jones Premium Only 2017-10-09 15:30:00 09/10/2017 -86.07%